Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation
Bernadette R. Gochuico(National Human Genome Research Institute), Alan Fine(Boston University), William W. Cruikshank(Boston University), Antoon J. M. van Oosterhout, Joris J. De Bie(Utrecht University), Edith M. Hessel(Eligo Bioscience (France)), Kathleen Miranda(Boston University)
American Journal of Physiology-Lung Cellular and Molecular Physiology
March 1, 1998
Cited by 55
Related Papers
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
|The Journal of Experimental Medicine|2010|740
Danazol Treatment for Telomere Diseases
|New England Journal of Medicine|2016|401
Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves’ Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway
|The Journal of Immunology|2003|294
Interleukin-16
|Journal of Leukocyte Biology|2000|277
Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression.
|Proceedings of the National Academy of Sciences|1994|270